mirror of
https://gitlab.silvrtree.co.uk/martind2000/ft-webplatform.git
synced 2025-02-12 08:59:17 +00:00
598 lines
25 KiB
JSON
598 lines
25 KiB
JSON
{
|
|
"globalProductsValue": {
|
|
"portfolioIntlValue": {
|
|
"fundID": {
|
|
"val": "4912"
|
|
},
|
|
"holdings": [
|
|
{
|
|
"fundID": {
|
|
"val": "4912"
|
|
},
|
|
"asOfDate": {
|
|
"val": "31/03/2017"
|
|
},
|
|
"hldingDetails": {
|
|
"lstDtls": [
|
|
{
|
|
"name": {
|
|
"val": "CELGENE CORP"
|
|
},
|
|
"rank": {
|
|
"val": "1"
|
|
},
|
|
"val": {
|
|
"val": "9.57"
|
|
},
|
|
"sectorName": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"sectorNameSTD": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"rolUp": {},
|
|
"asset": {},
|
|
"primFlag": {
|
|
"val": "Y"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "BIOGEN INC"
|
|
},
|
|
"rank": {
|
|
"val": "2"
|
|
},
|
|
"val": {
|
|
"val": "6.50"
|
|
},
|
|
"sectorName": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"sectorNameSTD": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"rolUp": {},
|
|
"asset": {},
|
|
"primFlag": {
|
|
"val": "Y"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "INCYTE CORP"
|
|
},
|
|
"rank": {
|
|
"val": "3"
|
|
},
|
|
"val": {
|
|
"val": "6.33"
|
|
},
|
|
"sectorName": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"sectorNameSTD": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"rolUp": {},
|
|
"asset": {},
|
|
"primFlag": {
|
|
"val": "Y"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "ALEXION PHARMACEUTICALS INC"
|
|
},
|
|
"rank": {
|
|
"val": "4"
|
|
},
|
|
"val": {
|
|
"val": "5.72"
|
|
},
|
|
"sectorName": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"sectorNameSTD": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"rolUp": {},
|
|
"asset": {},
|
|
"primFlag": {
|
|
"val": "Y"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "TESARO INC"
|
|
},
|
|
"rank": {
|
|
"val": "5"
|
|
},
|
|
"val": {
|
|
"val": "5.27"
|
|
},
|
|
"sectorName": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"sectorNameSTD": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"rolUp": {},
|
|
"asset": {},
|
|
"primFlag": {
|
|
"val": "Y"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "REGENERON PHARMACEUTICALS INC"
|
|
},
|
|
"rank": {
|
|
"val": "6"
|
|
},
|
|
"val": {
|
|
"val": "4.62"
|
|
},
|
|
"sectorName": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"sectorNameSTD": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"rolUp": {},
|
|
"asset": {},
|
|
"primFlag": {
|
|
"val": "Y"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "AMGEN INC"
|
|
},
|
|
"rank": {
|
|
"val": "7"
|
|
},
|
|
"val": {
|
|
"val": "4.04"
|
|
},
|
|
"sectorName": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"sectorNameSTD": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"rolUp": {},
|
|
"asset": {},
|
|
"primFlag": {
|
|
"val": "Y"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "GILEAD SCIENCES INC"
|
|
},
|
|
"rank": {
|
|
"val": "8"
|
|
},
|
|
"val": {
|
|
"val": "3.90"
|
|
},
|
|
"sectorName": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"sectorNameSTD": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"rolUp": {},
|
|
"asset": {},
|
|
"primFlag": {
|
|
"val": "Y"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "VERTEX PHARMACEUTICALS INC"
|
|
},
|
|
"rank": {
|
|
"val": "9"
|
|
},
|
|
"val": {
|
|
"val": "3.54"
|
|
},
|
|
"sectorName": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"sectorNameSTD": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"rolUp": {},
|
|
"asset": {},
|
|
"primFlag": {
|
|
"val": "Y"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "ILLUMINA INC"
|
|
},
|
|
"rank": {
|
|
"val": "10"
|
|
},
|
|
"val": {
|
|
"val": "2.65"
|
|
},
|
|
"sectorName": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"sectorNameSTD": {
|
|
"val": "Pharmaceuticals, Biotechnology & Life Sciences"
|
|
},
|
|
"rolUp": {},
|
|
"asset": {},
|
|
"primFlag": {
|
|
"val": "Y"
|
|
}
|
|
}
|
|
]
|
|
},
|
|
"calNameStd": {
|
|
"val": "EQUITY_AS_PCT_OF_TOTAL_INC_CASH"
|
|
}
|
|
}
|
|
],
|
|
"stats": {
|
|
"fundID": {
|
|
"val": "4912"
|
|
},
|
|
"totalNetAsset": {
|
|
"val": "$2,447,069,920.79"
|
|
},
|
|
"priceToBValWgtAvg": {
|
|
"val": "5.88"
|
|
},
|
|
"priceToCFlowWgtAvg": {
|
|
"val": "18.69"
|
|
},
|
|
"priceToEarnWgtAvg": {},
|
|
"avgCrdQltyRating": {},
|
|
"avgLifeWgtAvg": {},
|
|
"durationOADWgtAvg": {},
|
|
"maturityWgtAvg": {},
|
|
"yldToMatrtyWgtAvg": {},
|
|
"mktCapWgtAvg": {
|
|
"val": "31,535.37"
|
|
},
|
|
"nbrOfScrtyExclCash": {
|
|
"val": "121"
|
|
},
|
|
"nbrOfScrtyInclCash": {
|
|
"val": "122"
|
|
},
|
|
"portfolioTurnOverRatioTwlMth": {},
|
|
"nbrOfIssuers": {
|
|
"val": "112"
|
|
},
|
|
"yldToWorstWgtAvg": {},
|
|
"durntModWrstWgtAVg": {},
|
|
"asOfDate": {
|
|
"val": "31/03/2017"
|
|
},
|
|
"fundCategory": {
|
|
"val": "Equity"
|
|
},
|
|
"priceToEarningRatioFwd": {
|
|
"val": "20.17"
|
|
},
|
|
"weightedYield": {}
|
|
},
|
|
"breakdown": {
|
|
"brkdwnDet": [
|
|
{
|
|
"asOfDate": {
|
|
"val": "31/03/2017"
|
|
},
|
|
"brkDwnLst": {
|
|
"lstDtls": [
|
|
{
|
|
"name": {
|
|
"val": "Equity"
|
|
},
|
|
"rank": {
|
|
"val": "1"
|
|
},
|
|
"val": {
|
|
"val": "95.68"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "Fixed Income"
|
|
},
|
|
"rank": {
|
|
"val": "2"
|
|
},
|
|
"val": {
|
|
"val": "0.00"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "Cash & Cash Equivalents"
|
|
},
|
|
"rank": {
|
|
"val": "3"
|
|
},
|
|
"val": {
|
|
"val": "4.32"
|
|
}
|
|
}
|
|
]
|
|
},
|
|
"type": "ASSET_ALLOCATION"
|
|
},
|
|
{
|
|
"asOfDate": {
|
|
"val": "31/03/2017"
|
|
},
|
|
"brkDwnLst": {
|
|
"lstDtls": [
|
|
{
|
|
"name": {
|
|
"val": "Biotechnology"
|
|
},
|
|
"rank": {
|
|
"val": "1"
|
|
},
|
|
"val": {
|
|
"val": "83.94"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "Pharmaceuticals"
|
|
},
|
|
"rank": {
|
|
"val": "2"
|
|
},
|
|
"val": {
|
|
"val": "9.08"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "Life Sciences Tools & Services"
|
|
},
|
|
"rank": {
|
|
"val": "3"
|
|
},
|
|
"val": {
|
|
"val": "2.65"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "Cash & Cash Equivalents"
|
|
},
|
|
"rank": {
|
|
"val": "4"
|
|
},
|
|
"val": {
|
|
"val": "4.32"
|
|
}
|
|
}
|
|
]
|
|
},
|
|
"type": "SECTOR_ALLOCATION",
|
|
"calNameStd": {
|
|
"val": "TOTAL_PCT_OF_TOTAL"
|
|
},
|
|
"calType": {
|
|
"val": "% of Total"
|
|
}
|
|
},
|
|
{
|
|
"asOfDate": {
|
|
"val": "31/03/2017"
|
|
},
|
|
"brkDwnLst": {
|
|
"lstDtls": [
|
|
{
|
|
"name": {
|
|
"val": "<2.0 Billion"
|
|
},
|
|
"val": {
|
|
"val": "24.90"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "2.0-5.0 Billion"
|
|
},
|
|
"val": {
|
|
"val": "13.70"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "5.0-10.0 Billion"
|
|
},
|
|
"val": {
|
|
"val": "8.36"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "10.0-25.0 Billion"
|
|
},
|
|
"val": {
|
|
"val": "5.44"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "25.0-50.0 Billion"
|
|
},
|
|
"val": {
|
|
"val": "21.13"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": ">50.0 Billion"
|
|
},
|
|
"val": {
|
|
"val": "25.10"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "N/A"
|
|
},
|
|
"val": {
|
|
"val": "1.36"
|
|
}
|
|
}
|
|
]
|
|
},
|
|
"type": "MARKET_CAPITAL_ALLOCATION"
|
|
},
|
|
{
|
|
"asOfDate": {
|
|
"val": "31/03/2017"
|
|
},
|
|
"brkDwnLst": {
|
|
"lstDtls": [
|
|
{
|
|
"name": {
|
|
"val": "United States"
|
|
},
|
|
"rank": {
|
|
"val": "1"
|
|
},
|
|
"val": {
|
|
"val": "91.68"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "Canada"
|
|
},
|
|
"rank": {
|
|
"val": "2"
|
|
},
|
|
"val": {
|
|
"val": "0.92"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "United Kingdom"
|
|
},
|
|
"rank": {
|
|
"val": "3"
|
|
},
|
|
"val": {
|
|
"val": "0.92"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "Israel"
|
|
},
|
|
"rank": {
|
|
"val": "4"
|
|
},
|
|
"val": {
|
|
"val": "0.82"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "Netherlands"
|
|
},
|
|
"rank": {
|
|
"val": "5"
|
|
},
|
|
"val": {
|
|
"val": "0.69"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "Switzerland"
|
|
},
|
|
"rank": {
|
|
"val": "6"
|
|
},
|
|
"val": {
|
|
"val": "0.40"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "France"
|
|
},
|
|
"rank": {
|
|
"val": "7"
|
|
},
|
|
"val": {
|
|
"val": "0.14"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "Austria"
|
|
},
|
|
"rank": {
|
|
"val": "8"
|
|
},
|
|
"val": {
|
|
"val": "0.10"
|
|
}
|
|
},
|
|
{
|
|
"name": {
|
|
"val": "Cash & Cash Equivalents"
|
|
},
|
|
"rank": {
|
|
"val": "9"
|
|
},
|
|
"val": {
|
|
"val": "4.32"
|
|
}
|
|
}
|
|
]
|
|
},
|
|
"type": "COUNTRY_ALLOCATION",
|
|
"calNameStd": {
|
|
"val": "EQT_AND_FIXED_INC_CTRY_BRKDN_PCT_OF_TOTAL_INCL_CASH"
|
|
},
|
|
"calType": {
|
|
"val": "% of Total"
|
|
}
|
|
},
|
|
{
|
|
"asOfDate": {
|
|
"val": "31/03/2017"
|
|
},
|
|
"brkDwnLst": {
|
|
"lstDtls": [
|
|
{
|
|
"name": {
|
|
"val": "USD"
|
|
},
|
|
"val": {
|
|
"val": "2,447,069,920.79"
|
|
},
|
|
"name2": {}
|
|
}
|
|
]
|
|
},
|
|
"type": "PRODUCT_AUM"
|
|
}
|
|
]
|
|
}
|
|
}
|
|
}
|
|
} |